期刊
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
卷 10, 期 2, 页码 131-136出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/187152010790909254
关键词
Cancer stem cells; Melanoma; Malignant melanoma-initiating cells; Melanoma stem cells; ABCB5; Angiogenesis; Immunity
资金
- NIH/NCI [1RO1CA113796-04, 1R01CA138231-02, 2P50CA093683-05S2]
Cancer stem cells (CSCs), also known as tumor-initiating cells, have been identified in several human malignancies, including human malignant melanoma. The frequency of malignant melanoma-initiating cells (MMICs), which are identified by their expression of ATP-binding cassette (ABC) family member ABCB5, correlates with disease progression in human patients. Furthermore, targeted MMIC ablation through ABCB5 inhibits tumor initiation and growth in preclinical xenotransplantation models, pointing to potential therapeutic promise of the CSC concept. Recent advances also show that CSCs can exert pro-angiogenic roles in tumor growth and serve immunomodulatory functions related to the evasion of host anti-tumor immunity. Thus, MMICs might initiate and sustain tumorigenic growth not only as a result of CSC-intrinsic self-renewal, differentiation and proliferative capacity, but also based on pro-tumorigenic interactions with the host environment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据